PMOS / PCOS Long Term Health

Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome

Yildirim B, Sabir N, Kaleli B

Published June 12, 2003 Fertility and Sterility, 79(6), 1358-1364
DOI 10.1016/s0015-0282(03)00265-6 PMID 12798883

RRM Academy Synopsis

Lean women with PCOS carry more visceral fat than controls

Lean women with PCOS (also called PMOS, Polyendocrine Metabolic Ovarian Syndrome) had thicker visceral and preperitoneal fat than lean controls on ultrasound. The case-control study included 30 women per group. Among the women with PCOS, thicker visceral fat went with higher triglycerides and fasting insulin.

Key Findings

  • Visceral fat thickness averaged 16.7 mm in the PCOS group and 9.4 mm in controls (P = .0001); preperitoneal fat averaged 8.3 mm and 4.9 mm (P = .0001).
  • Subcutaneous fat thickness was similar between groups: 10.3 mm with PCOS and 8.9 mm in controls (not significant).
  • Insulin area under the curve during the glucose tolerance test was significantly higher with PCOS than in controls (P < .001). It correlated with visceral fat thickness (r = .573).
  • Among the women with PCOS, regression showed visceral fat thickness contributing to both triglycerides (P < .0001) and fasting insulin (P < .0001).

Interpretation

The study is a prospective case-control comparison of 30 lean women with PCOS and 30 lean controls at one university hospital in Turkey. All had a body mass index under 25, so the findings describe lean women. Ultrasound measured fat thickness at set abdominal sites. In the women with PCOS, visceral and preperitoneal fat thickness correlated with triglycerides, HDL cholesterol and insulin measures, and subcutaneous fat thickness showed no such correlation. The authors propose visceral fat as a possible early marker of metabolic disorders in lean women with PCOS.

RRM Context

Restorative reproductive medicine treats PCOS as both a metabolic and an ovulation problem. The lean women here still had significantly higher insulin than controls, so a normal weight does not settle the metabolic questions. A cause-based workup checks them alongside the cycle chart.

Abstract

Objective

To investigate the relation between intra-abdominal fat distribution and metabolic disorders in nonobese patients with the polycystic ovary syndrome (PCOS).

Design

Prospective case-control study.

Setting

University-based hospital.

Patients

Thirty nonobese patients with PCOS and 30 lean women with regular menstrual cycles (controls). All participants had a body mass index < 25kg/m(2).

Main Outcome Measures

Subcutaneous and intra-abdominal visceral and preperitoneal fat thicknesses were assessed by ultrasonography. Glucose tolerance and insulin sensitivity were evaluated by standard 75-g oral glucose tolerance test and area-under-the-curve analysis. Serum hormones and lipid profile were measured.

Results

The mean preperitoneal and visceral fat thicknesses were significantly greater in nonobese patients with PCOS. Subcutaneous fat mass was similar between the PCOS and control groups. Nonobese patients with PCOS had glucose intolerance, hyperinsulinemia, and dyslipidemia, manifested by high serum levels of triglyceride, total cholesterol, and high-density lipoprotein (HDL) levels and low serum low-density lipoprotein (LDL) levels. No correlation existed between subcutaneous fat thickness and the metabolic variables in nonobese patients with PCOS. However, serum triglyceride levels correlated with visceral fat and preperitoneal fat thickness. The mean HDL level correlated negatively with visceral fat and preperitoneal fat thickness. The area under the curve for insulin and mean fasting insulin levels correlated positively with visceral fat thickness. In multiple regression analysis, visceral fat thickness contributed significantly to high serum triglyceride and fasting insulin levels.

Conclusions

Intra-abdominal preperitoneal and visceral fat accumulation may contribute to the development of glucose and lipid metabolism disorders in nonobese patients with PCOS.

Read the guide

  • PMOS / PCOS: Causes, Diagnosis, and Treatment

    PMOS / PCOS has four diagnostic phenotypes and distinct metabolic, reproductive, and mental health implications. How RRM-trained clinicians approach diagnosis and treatment differently.

    20 min read

Topics

Related research

PMOS / PCOS › Long Term Health › Metabolic Risk · Diagnostics › Ultrasound › Transvaginal Ultrasound
Basak Yildirim, Nuran Sabir, Babur Kaleli
B Yildirim, N Sabir, B Kaleli
PMID 12798883 12798883 DOI 10.1016/s0015-0282(03)00265-6 10.1016/s0015-0282(03)00265-6 Yildirim et al. 2003, Yildirim 2003